- Home
- DARE vs MNDO Comparison
DARE vs MNDO Comparison
Compare DARE & MNDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DARE
- MNDO
- Stock Information
- Founded
- DARE 2015
- MNDO 1995
- Country
- DARE United States
- MNDO Israel
- Employees
- DARE N/A
- MNDO N/A
- Industry
- DARE Biotechnology: Pharmaceutical Preparations
- MNDO EDP Services
- Sector
- DARE Health Care
- MNDO Technology
- Exchange
- DARE Nasdaq
- MNDO Nasdaq
- Market Cap
- DARE 28.6M
- MNDO 24.4M
- IPO Year
- DARE N/A
- MNDO 2000
- Fundamental
- Price
- DARE $2.05
- MNDO $1.07
- Analyst Decision
- DARE Strong Buy
- MNDO
- Analyst Count
- DARE 2
- MNDO 0
- Target Price
- DARE $10.00
- MNDO N/A
- AVG Volume (30 Days)
- DARE 197.7K
- MNDO 32.3K
- Earning Date
- DARE 11-13-2025
- MNDO 11-04-2025
- Dividend Yield
- DARE N/A
- MNDO 20.37%
- EPS Growth
- DARE N/A
- MNDO N/A
- EPS
- DARE N/A
- MNDO 0.15
- Revenue
- DARE N/A
- MNDO $20,155,000.00
- Revenue This Year
- DARE $6,864.02
- MNDO N/A
- Revenue Next Year
- DARE $4,922.46
- MNDO N/A
- P/E Ratio
- DARE N/A
- MNDO $7.20
- Revenue Growth
- DARE N/A
- MNDO N/A
- 52 Week Low
- DARE $1.83
- MNDO $1.02
- 52 Week High
- DARE $9.19
- MNDO $2.13
- Technical
- Relative Strength Index (RSI)
- DARE 46.22
- MNDO 39.70
- Support Level
- DARE $2.01
- MNDO $0.98
- Resistance Level
- DARE $2.28
- MNDO $1.14
- Average True Range (ATR)
- DARE 0.10
- MNDO 0.04
- MACD
- DARE -0.01
- MNDO -0.00
- Stochastic Oscillator
- DARE 25.00
- MNDO 47.03
About DARE Dare Bioscience Inc.
Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.
About MNDO MIND C.T.I. Ltd.
MIND C.T.I. Ltd develops, manufactures, markets, and implements real-time and off-line convergent billing and customer care software solutions. It derives revenue from the sale of software products and services in two reportable segments, namely Billing and Related Services, which derives key revenue, and Messaging. The company has three product lines: Product Line A- billing and customer care solutions for service providers; Product Line B - call accounting and call management solutions for enterprises; and Product Line C - mobile messaging, communication, and payment solutions. Geographically, the company operates in the Americas, Europe, Asia Pacific and Africa, and Israel. It earns maximum revenue from Europe.